Newland Pharmaceutical Co., Ltd. (SHE:301277)
11.53
0.00 (0.00%)
Apr 29, 2026, 4:00 PM EDT
-2.37% (1Y)
| Market Cap | 4.52B |
| Revenue (ttm) | 659.54M |
| Net Income (ttm) | 100.78M |
| Shares Out | 392.08M |
| EPS (ttm) | 0.26 |
| PE Ratio | 44.75 |
| Forward PE | n/a |
| Dividend | 0.20 (1.73%) |
| Ex-Dividend Date | Apr 30, 2026 |
| Volume | 1,943,940 |
| Average Volume | 3,290,859 |
| Open | 11.46 |
| Previous Close | 11.53 |
| Day's Range | 11.44 - 11.68 |
| 52-Week Range | 10.80 - 18.38 |
| Beta | 0.45 |
| RSI | 41.79 |
| Earnings Date | Apr 24, 2026 |